Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment.

Cathy Anne PintoGin Nie ChuaJohn F P BridgesElla BrookesJohanna HyacintheTommi Tervonen

Published in: The patient (2021)

Patient preferences for antithrombotic treatments were unaffected by disease stage but varied by bleeding risk and other factors. This heterogeneity in preferences is an important consideration because it can affect the benefit-risk balance and the acceptability of antithrombotic treatments to patients.

Keyphrases

atrial fibrillation
end stage renal disease
case report
decision making
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
liver failure
prognostic factors
peritoneal dialysis
left ventricular
single cell
drug induced
aortic dissection
patient reported
smoking cessation
replacement therapy